Dr. Jacob Thomas Ankeny, MD, MPH, MBA Preventive Medicine - Occupational Medicine Medicare: Medicare Enrolled Practice Location: 212 Wallace Creek Rd, Camp Lejeune, NC 28547 Phone: 910-450-8330 Fax: 910-449-8408 |
Neil M King, MD Preventive Medicine - Aerospace Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 Brewster Blvd, Psc 351, Camp Lejeune, NC 28547 Phone: 910-450-4520 |
Dr. Timothy Mattison, DO Preventive Medicine - Aerospace Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 Brewster Blvd Bldg H100, Camp Lejeune, NC 28547 Phone: 910-450-4800 |
News Archive
The final version of the massive opioid bill Congress released Wednesday would grant the Food and Drug Administration new powers to crack down on drug imports, but it also includes a provision — nearly killed in the Senate — to shield people who are just trying to buy cheaper, needed prescription medication from other countries.
International biotechnology firm Cytonet recently launched the first ever clinical trial in the United States using an investigational liver cell infusion to treat urea cycle disorders (UCD) in children. The first patient in the Phase II trial, which will seek to enroll 20 patients in 12 medical centers, is a child with citrullinemia, which is a hereditary UCD. He received six liver cell infusions on six consecutive days at Yale School of Medicine in New Haven, Conn.
The U.N. Office on Drugs and Crime (UNODC) on Wednesday released a report - "Addiction, Crime and Insurgency: The Transnational Threat of Afghan Opium" - documenting how "[t]he smuggling of Afghan opiates is fueling addiction and drug use along trafficking routes from Iran to Central Asia," and contributing to the spread of diseases, the Associated Press reports (Oleksyn, 10/21).
Mind-body therapies – biofeedback, mindfulness, yoga, and hypnosis – provide a promising approach to the very common problem of anxiety in adolescents, according to a review in the March issue of The Nurse Practitioner.
In a world first, Dr. Andres M. Lozano and his team at Toronto Western Hospital has shown using Deep Brain Stimulation (DBS) on patients with early signs of Alzheimer's disease is safe and may help improve memory. The phase one safety trial of six Ontario patients took place from 2005 to 2008. All patients left hospital within 2 to 3 days of surgery, and continue to participate in regular follow-up cognitive assessments.
› Verified 5 days ago